EGI
OXFD

EAM Global Investors’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

EAM Global Investors’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-77,195
Closed -$1.33M – 165
2019
Q1 		$1.33M Buy
+77,195
New +$1.22M 0.59% 92

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

EAM Global Investors's OXFD Position: Q2 2019 in Review

EAM Global Investors sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2019, closing a stake of 77,195 shares — an estimated $1.33M sold.

EAM Global Investors first reported a position in OXFD in Q1 2019 and held it in 1 quarter. The position peaked at $1.33M in Q1 2019. 86 funds tracked by Wall St. Rank hold OXFD as of Q2 2019.

  • EAM Global Investors reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2019 after selling out during the quarter.
  • EAM Global Investors sold 77,195 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2019, an estimated $1.33M.
  • EAM Global Investors first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2019 and held it in 1 quarter.
  • EAM Global Investors's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.33M in Q1 2019.
  • 86 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2019.

Based on EAM Global Investors's 13F filing for Q2 2019, filed 14 Aug 2019.